Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) (C-Term) Peptid
PLA2G4B
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PLA2G4B Produkte
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SFREYSAPGV RRTPEEAAAG EVNLSSSDSP YHYTKVTYSQ EDVDKLLHLT
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- PLA2G4B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
- Hintergrund
-
This locus represents naturally-occurring readthrough transcription between the neighboring jumonji domain containing 7 (JMJD7) and phospholipase A2, group IVB (cytosolic) (PLA2G4B) genes. Readthrough transcripts encode fusion proteins that share amino acid sequence with each individual gene product, including a partial JmjC domain and downstream C2 and phospholipase A2 domains. Alternatively spliced transcript variants have been observed.
Alias Symbols: HsT16992, cPLA2-beta
Protein Size: 482 - Gen-ID
- 8681
- NCBI Accession
- NM_001114633, NP_001108105
-
Sie sind hier:
